Therefore, we hypothesized that PRKCA could attenuate the inflammation of NPs by activating TGF-β signaling pathway and inhibiting WNT signaling pathway, thereby improving IDD. The gene discussed is PRKCA; the disease is intervertebral disk degenerative disorder.